BCDA Archives - Spark Newswire

On Friday before the market open, BioCardia announced it received approval from the United States Patent Office for its application entitled, "Radial and Transendocardial Delivery Catheter."

BCDA

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

June 7, 8:08 AM

Gainers Venus Concept (NASDAQ:VERO) shares increased by 135.2% to $1.38 during Friday’s pre-market session. The market value of…

ANL

2 minute read

Expensify And 2 Other Stocks Under $2 Insiders Are Buying

By Avi Kapoor

April 22, 7:38 AM

The Dow Jones index closed higher by over 200 points on Friday. When insiders purchase or sell shares,…

BCDA

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

March 29, 8:06 AM

Gainers Avalo Therapeutics (NASDAQ:AVTX) stock rose 289.1% to $18.48 during Friday’s pre-market session. The market value of their…

AKAN

1 minute read

Earnings

BioCardia: Q4 Earnings Insights

By Benzinga Insights

March 27, 4:10 PM

BioCardia (NASDAQ:BCDA) reported its Q4 earnings results on Wednesday, March 27, 2024 at 04:00 AM. Here’s what investors…

BCDA

4 minute read

Earnings

Earnings Scheduled For March 27, 2024

By Benzinga Insights

March 27, 5:02 AM

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.

AGAE

4 minute read

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Avi Kapoor

January 19, 2:05 PM

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

ABSI

Feed Symbols: BCDA